Drug
Colesevelam clinical trials
Also written Welchol, IW-3718 and Cholestagel.
- studies test it
- 52
- open now
- 4
- in phase 3
- 13
- first study started
- 2001
Keep track of what changes. Save the colesevelam studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
52 studies that test it; most in 2009 (6)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 1 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 4
- Phase 2
- 13
- Phase 3
- 13
- Phase 4
- 19
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 23 · Other 29
Daiichi Sankyo (15) · Mayo Clinic (6) · Ironwood Pharmaceuticals, Inc. (5) · Hvidovre University Hospital (3) · University Hospital, Gentofte, Copenhagen (3) · Filip Krag Knop (2) · Genzyme, a Sanofi Company (2) · Spanish Breast Cancer Research Group (1)
Often tested with
Tested in the same studies.
Metformin (3) · Chenodeoxycholic Acid (2) · Clonidine (1) · Niacin (1) · Liraglutide (1) · Thyroxine (1) · Glyburide (1) · Digoxin (1)
Studies
Open first, then newest update. How each study uses colesevelam is read from its arms, and is right about nine times in ten.
Testing it · 52
- Use of Bile Acid Binding Resins to Decrease PFAS Levels Via Colesevalem in Veterans StudyNot yet recruitingPhase 2University of Rhode IslandNCT07592858Written as Colesevelam
- Examining a Novel Gastrointestinal Intervention to Negate Environmental Toxicants (ENGINE)RecruitingPhase 1/2University of California, San FranciscoNCT07226440Written as Colesevelam
- Metabolic Effects of Endogenous Bile Acids After Gastric Bypass SurgeryRecruitingEarly Phase 1Hvidovre University HospitalNCT06925997Written as Colesevelam
- Impact of Therapy Using Colesevelam Treatment Reducing Bile Acids in Patients With Fontan Circulation.Not yet recruitingPhase 1/2St. Boniface HospitalNCT06197763Written as Colesevelam
- Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant NeratinibActive, not recruitingPhase 2Spanish Breast Cancer Research GroupNCT05252988Written as Colesevelam
- A Study of Colesevelam in Fecal IncontinenceCompletedPhase 3Mayo ClinicNCT02628626Written as Colesevelam
- Effect of the Sequestrant Colesevelam in Bile Acid DiarrhoeaCompletedPhase 4Lars Kristian MunckNCT03876717Written as Colesevelam Hydrochloride
- Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol MedicationCompletedPhase 4University of WashingtonNCT00715273Written as Colesevelam
- Treatment of Bile Acid Malabsorption With LiraglutideCompletedPhase 4Filip Krag KnopNCT03955575Written as Colesevelam
- A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)TerminatedPhase 3Ironwood Pharmaceuticals, Inc.NCT03561090Written as IW-3718
- Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)CompletedPhase 3Ironwood Pharmaceuticals, Inc.NCT03561883Written as IW-3718
- Colesevelam for Children With Type 2 DiabetesCompletedPhase 4Daiichi SankyoNCT01258075Written as High-dose colesevelam
- Effect of Bile Acids and Bile Acid Sequstrants on GLP-1 Secretion After Roux-en-Y Gastric BypassCompletedPhase 4Hvidovre University HospitalNCT02952963Written as Colesevelam
- Effects of Bile Acids and Bile Acid Sequestrants on GLP-1 Secretion After Roux-en-Y Gastric BypassCompletedPhase 4Hvidovre University HospitalNCT02876484Written as Colesevelam
- Effects of Fish Oil and Colesevelam (STAIR7007)Status unknownNot applicableUniversity of ManitobaNCT01948648Written as Colesevelam
- Colesevelam Versus Placebo in the Treatment of Nonalcoholic SteatohepatitisCompletedPhase 2University of California, San DiegoNCT01066364Written as Colesevelam Hcl
- Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid MalabsorptionCompletedPhase 2Mayo ClinicNCT03270085Written as Colesevelam
- Randomized Trial Comparing Colesevelam vs. EzetimibeCompletedPhase 4LMC Diabetes & Endocrinology Ltd.NCT02682680Written as Colesevelam
- A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)CompletedPhase 2Ironwood Pharmaceuticals, Inc.NCT02637557Written as IW-3718
- Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult VolunteersCompletedPhase 1Ironwood Pharmaceuticals, Inc.NCT03856970Written as IW-3718
See all 52 studies that test colesevelam →
Given in every arm · 1 — colesevelam is usual care beside what is tested
Codes
What other systems call colesevelam · ClinicalTrials.gg INT006596
- MeSH (NLM) D000069472Colesevelam HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 1XU104G55NCOLESEVELAMConfirmed FDA, NLM, Wikidata
- RxNorm 141626Confirmed FDA, Wikidata
- Wikidata Q899036colesevelamConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C78056ColesevelamConfirmed FDA, Wikidata
- DrugBank DB00930One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069472 | Colesevelam Hydrochloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 1XU104G55N | COLESEVELAM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 141626 | — | Confirmed FDA, Wikidata |
| Wikidata | Q899036 | colesevelam | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C78056 | Colesevelam | Confirmed FDA, Wikidata |
| DrugBank | DB00930 | — | One source Wikidata |
Also registered as colesevelam hydrochloride (UNII P4SG24WI5Q · RxNorm 141625).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.